Literature DB >> 20619744

Sexual function in teenagers after multimodal treatment of pelvic rhabdomyosarcoma: A preliminary report.

Antonio Macedo1, Pedro Vanalle Ferreira, Ubirajara Barroso, Guilherme T Demarchi, Gilmar Garrone, Riberto Liguori, Eliana Caran, Valdemar Ortiz.   

Abstract

OBJECTIVE: The multimodal approach to treatment of genitourinary rhabdomyosarcoma (RMS) has improved survival rates, but there is now a focus on the effect on quality of life. Our aim was to evaluate erectile function in children with rhabdomyosarcoma (RMS) who underwent chemotherapy, radiotherapy, cystectomy and continent urinary diversion.
MATERIAL AND METHODS: We evaluated four eligible patients (age > 14 years) from our genitourinary RMS database. In two patients the reservoir was constructed at the same time of the cystectomy and in two after undiversion of an ileal conduit. All patients were treated with chemotherapy and radiation therapy before cystectomy. We used a questionnaire to estimate erectile function in adolescents and young adults. There were four questions, each one to be scored 1-5, assessing capability to masturbate.
RESULTS: Mean follow up after cystectomy was 9.75 years. We considered that two patients had erections of good quality (scores 18 and 20) and two of moderate quality (scores 8 and 10). One patient had a good response to sildenafil administration.
CONCLUSION: Our data demonstrate that it is possible to keep erectile function during masturbation in children with RMS who have undergone chemotherapy, radiotherapy, cystectomy and continent urinary diversion.
Copyright © 2010 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20619744     DOI: 10.1016/j.jpurol.2010.06.001

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  4 in total

1.  Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group.

Authors:  Lisa B Kenney; Laurie E Cohen; Margarett Shnorhavorian; Monika L Metzger; Barbara Lockart; Nobuko Hijiya; Eileen Duffey-Lind; Louis Constine; Daniel Green; Lillian Meacham
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

2.  Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.

Authors:  Abha A Gupta; Yueh-Yun Chi; James R Anderson; Elizabeth Lyden; Brenda Weigel; Carola Arndt; William H Meyer; Abby Rosenberg; Douglas S Hawkins
Journal:  Pediatr Blood Cancer       Date:  2017-03-23       Impact factor: 3.167

3.  Optimal surgical treatment and urological outcomes in boys with pelvic and urogenital rhabdomyosarcomas and soft tissue sarcomas.

Authors:  Tomoro Hishiki; Takeshi Saito; Tetsuya Mitsunaga; Mitsuyuki Nakata; Elena Terui; Shugo Komatsu; Naoko Mise; Kazuaki Harada; Jun Iwai; Yasuyuki Higashimoto; Yuri Okimoto; Harumi Kakuda; Hidemasa Ochiai; Moeko Hino; Sumie Homma; Yuichi Osa; Hideo Yoshida
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

4.  Appraisal of the role of radical prostatectomy for rhabdomyosarcoma in children: oncological and urological outcome.

Authors:  Lorenzo Angelini; Gianni Bisogno; Ciro Esposito; Marco Castagnetti
Journal:  Ther Adv Urol       Date:  2018-03-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.